Previous close | 35.34 |
Open | 34.65 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 34.58 - 34.75 |
52-week range | 31.02 - 53.91 |
Volume | |
Avg. volume | 507 |
Market cap | 23.071M |
Beta (5Y monthly) | 1.46 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Appian (APPN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Appian (APPN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Petrus Advisers shifted to an active stance on the ad-tech firm Criteo. Summer Road lifted its stake in biotech Ocular.